Related Experiment Videos
Blood clotting activation during normal pregnancy
P Comeglio1, S Fedi, A A Liotta
1Istituto di Clinica Medica Generale e Cardiologia, University of Florence, Italy.
Thrombosis Research
|November 1, 1996
Summary
Pregnancy elevates clotting factors, making it hard to detect blood clots. This study establishes normal ranges for prothrombin fragment 1+2 (F1+2) during pregnancy to aid in diagnosing thromboembolic events.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Thrombosis Research
Background:
- Pregnancy is a hypercoagulable state with increased thromboembolic risk.
- Physiological pregnancy involves elevated coagulation factors, enhanced thrombin generation, and suppressed fibrinolysis.
- Rising fibrinogen and D-dimer levels in pregnancy complicate thromboembolic event diagnosis.
Purpose of the Study:
- To determine reference ranges for prothrombin fragment 1+2 (F1+2) plasma levels during normal pregnancy.
- To provide a baseline for interpreting F1+2 levels in pregnant women.
- To investigate the behavior of F1+2 during different stages of pregnancy.
Main Methods:
- Preliminary study design.
- Measurement of plasma prothrombin fragment 1+2 (F1+2) levels.
- Analysis of F1+2 levels across different trimesters of normal pregnancy.
Main Results:
- Establishment of preliminary range values for F1+2 plasma levels.
- Characterization of F1+2 level trends during physiological pregnancy.
- Data provides a basis for understanding coagulation activation in pregnancy.
Conclusions:
- Prothrombin fragment 1+2 (F1+2) levels exhibit specific behavior during normal pregnancy.
- Establishing pregnancy-specific F1+2 ranges is crucial for accurate thromboembolic diagnosis.
- Further research is needed to validate these findings and their clinical utility.